This document is an excerpt from the EUR-Lex website
Document 22023D0348
Decision of the EEA Joint Committee No 34/2020 of 20 March 2020 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/348]
Decision of the EEA Joint Committee No 34/2020 of 20 March 2020 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/348]
Decision of the EEA Joint Committee No 34/2020 of 20 March 2020 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/348]
OJ L 57, 23.2.2023, p. 10–11
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Date of entry into force unknown (pending notification) or not yet in force.
|
23.2.2023 |
EN |
Official Journal of the European Union |
L 57/10 |
DECISION OF THE EEA JOINT COMMITTEE No 34/2020
of 20 March 2020
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/348]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2019/716 of 30 April 2019 amending Implementing Regulations (EU) No 22/2013 and (EU) No 540/2011 as regards the conditions of approval of the active substance cyflumetofen (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Regulation (EU) 2019/1589 of 26 September 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Commission Implementing Regulation (EU) 2019/1605 of 27 September 2019 approving the low-risk active substance Bacillus subtilis strain IAB/BS03, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (3) is to be incorporated into the EEA Agreement. |
|
(4) |
Commission Implementing Regulation (EU) 2019/1690 of 9 October 2019 renewing the approval of the active substance alpha-cypermethrin, as a candidate for substitution, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (4) is to be incorporated into the EEA Agreement. |
|
(5) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:
|
1. |
The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):
|
|
2. |
The following is added in point 13zx (Commission Implementing Regulation (EU) No 22/2013): ‘, as amended by:
|
|
3. |
The following points are inserted after point 13zzzzzzzzzzh (Commission Implementing Regulation (EU) 2019/1138):
|
Article 2
The texts of Implementing Regulations (EU) 2019/716, (EU) 2019/1589, (EU) 2019/1605 and (EU) 2019/1690 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 21 March 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 20 March 2020.
For the EEA Joint Committee
The President
Clara GANSLANDT
(1) OJ L 122, 10.5.2019, p. 39.
(2) OJ L 248, 27.9.2019, p. 24.
(3) OJ L 250, 30.9.2019, p. 49.
(4) OJ L 259, 10.10.2019, p. 2.
(*1) No constitutional requirements indicated.